Psychiatry and Neurology, Neurology · Foxboro, MA
NPI
1588715882
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
18 Washington St
Foxboro, MA, 02035
Phone (781) 551-5812
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.0M
426,521 services
Medicare patients, 2024
430
Average age 67
Drug cost, 2024
$4.1M
1,501 prescriptions
Company payments, 2025
$56K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salvatore Q Napoli was code J0174 (injection, lecanemab-irmb, 1 mg), 247,597 times for 31 patients. In total Salvatore Q Napoli billed 426,521 services in 68 codes, and Medicare paid $5.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 247,597 | 31 | $1.05 | $260K |
| J2350 Injection, ocrelizumab, 1 mg | Office | 36,903 | 40 | $39.57 | $1.5M |
| J2323 Injection, natalizumab, 1 mg | Office | 26,719 | 12 | $18.56 | $496K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 25,500 | 38 | $4.86 | $124K |
| J1306 Injection, inclisiran, 1 mg | Office | 9,372 | 18 | $9.53 | $89K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 8,100 | 40 | $0.23 | $1,853 |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 6,909 | 12 | $14.41 | $100K |
| J3245 Injection, tildrakizumab, 1 mg | Office | 5,604 | 18 | $107.50 | $602K |
| 96413 Chemotherapy Administration | Office | 507 | 102 | $104.78 | $53K |
| 96365 Intravenous Infusion, Hydration | Office | 362 | 68 | $51.25 | $19K |
| 96375 Injection Administration | Office | 361 | 48 | $12.32 | $4,447 |
| 99458 E&M - Miscellaneous | Office | 234 | 28 | $28.88 | $6,757 |
| 99457 E&M - Miscellaneous | Office | 216 | 29 | $36.69 | $7,924 |
| 99454 E&M - Miscellaneous | Office | 213 | 29 | $37.22 | $7,927 |
| 99214 Office E&M - Established | Office | 211 | 132 | $91.91 | $19K |
By year: 2022 $1.5M for 51,627 services; 2023 $3.3M for 115,478 services; 2024 $5.0M for 426,521 services.
Medicare prescription drug claims, 2024
In 2024, the drug Salvatore Q Napoli prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 190 prescriptions and refills. In total Salvatore Q Napoli wrote 1,501 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 190 | 255 | 39 | $90K |
| Gabapentin Generic | 162 | 223 | 41 | $3,953 |
| Baclofen Generic | 132 | 263 | 40 | $5,409 |
| Kesimpta Pen Ofatumumab | 81 | 81 | 13 | $713K |
| Aubagio Teriflunomide | 59 | 71 | Under 11 | $649K |
| Copaxone Glatiramer Acetate | 52 | 52 | Under 11 | $289K |
| Ampyra Dalfampridine | 44 | 54 | Under 11 | $228K |
| Tysabri Natalizumab | 34 | 34 | Under 11 | $284K |
| Levetiracetam Generic | 33 | 55 | 13 | $1,156 |
| Dimethyl Fumarate Generic | 33 | 33 | Under 11 | $4,552 |
| Glatopa Glatiramer Acetate | 29 | 29 | Under 11 | $102K |
| Teriflunomide Generic | 28 | 34 | Under 11 | $62K |
| Nurtec Odt Rimegepant Sulfate | 22 | 22 | Under 11 | $36K |
| Oxcarbazepine Generic | 21 | 46 | Under 11 | $1,463 |
| Amantadine Amantadine Hcl | 21 | 28 | Under 11 | $258 |
Brand drugs: 494 claims; generic drugs: 1,007 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salvatore Q Napoli $56K ($56K in general payments such as food, travel and fees) from 29 companies. The largest payer was Biogen, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 10 | $14K |
| Mallinckrodt Hospital Products Inc. | 9 | $12K |
| EMD Serono, Inc. MRK.DE | 32 | $8,753 |
| Eisai Inc. 4523.T | 13 | $7,320 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $3,703 |
| Eisai Co., Ltd. 4523.T | 1 | $3,675 |
| TG Therapeutics, Inc. TGTX | 5 | $2,767 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $2,050 |
| SK Life Science, Inc. | 11 | $326 |
| Life Molecular Imaging Ltd | 2 | $247 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.